California's “Angel of Death” Was a Notorious Killer. Then an Unlikely Team of Scientists Cracked the Case.

In October 2001 a Los Angeles County grand jury indicted Saldivar on six counts of murder and one count of attempted murder.
The Healthy @Reader's Digest on MSN

I ate soup every day for a week—here’s what happened

If you've been craving soup season, a doctor lifts the lid on science that shows soup really does have healing powers and ...
Le Lézard

Harmony Biosciences Guides to Over $1 Billion in WAKIX® Revenue in 2026; Advancing Robust Late-Stage Pipeline With Potential for Long-term Value Creation

Harmony Biosciences Holdings, Inc. today announced strong preliminary, unaudited net product revenue for Q4 and full year ...

Auckland-Vancouver flight aborted after pilots detect strange smell

The flight itself was scheduled to depart at 2:00 pm local time on Tuesday, but only took off after a 50-minute delay. Just ...
Watauga Democrat

Ask the doctors: Shoveling snow quickly puts strain on heart

I’m 65 and healthy. I actually like shoveling snow because it keeps me active. My grandson and my wife say I’m asking for a heart attack and are ...
Idaho State Journal

The Metabolic Clinic of Idaho now open in Chubbuck

Standard Western medicine is reactive medicine. It primarily focuses on diagnosing and treating symptoms and diseases using ...

Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the novel TOGETHER-PsA open-label Phase 3b ...

Mereo BioPharma Provides Corporate Update

Additional data analyses from Orbit and Cosmic Phase 3 studies of setrusumab (UX143) in osteogenesis imperfecta ongoing to determine potential path forward for the program Cash balance of ...

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States

Detailed price information for Fortress Biotech Inc (FBIO-Q) from The Globe and Mail including charting and trades.
Le Lézard

RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer

Johnson & Johnson today announced new longer follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating amivantamab-vmjw, a bispecific antibody targeting epidermal growth factor ...

Johnson & Johnson: RYBREVANT (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

Fortress Biotech, Inc.: Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO (copper histidinate), the First and Only Approved Treatment for Menkes ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 milli ...